http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-38435-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bab34457c0c62aadf06ac0280240a61
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
filingDate 2019-10-31^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_901141bc3000220a7071c4f5b720d72f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_104a75602f95389da2b22d9f3b832657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd2947df8dfabbe625925a07fd7a7422
publicationDate 2020-05-29^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UY-38435-A
titleOfInvention NEW UREA 6,7-DIHIDRO-4H-PIRAZOL [1,5-A] PIRAZINAS ACTIVE AGAINST THE VIRUS OF HEPATITIS B (HBV)
abstract The present invention relates, in general, to new antiviral agents. Specifically, the present invention relates to compounds that can inhibit the protein (s) encoded by the hepatitis B virus (HBV) or interfere with the function of the replication cycle of HBV, to compositions comprising said compounds, to methods for inhibiting the replication of the HBV virus, methods for treating or preventing HBV infection and processes and intermediates for the manufacture of the compounds.
priorityDate 2018-11-02^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176

Showing number of triples: 1 to 20 of 20.